Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. Its research equipment includes HPX hyperpolarizer, HPX measurement station, HPX gas manifold, chest coil, and dose delivery bags. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.
Stock data | 2024 | Change |
---|---|---|
Price | $0.020617236690998856 | N/A |
Market Cap | $4.45M | N/A |
Shares Outstanding | 215.85M | N/A |
Employees | 28.00 | N/A |